Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05525286
Title Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma (CLAUDIO-01)
Acronym CLAUDIO-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors SOTIO Biotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CZE | BEL


No variant requirements are available.